相良匡昭　SAGARA MASAAKI　サガラ マサアキ

研究者情報

研究者情報

• 氏名

  相良匡昭, サガラ マサアキ

所属

• 内科学(内分泌代謝)(壬生), 病院助教

研究業績

論文

原著論文
• Effect of growth hormone replacement therapy on plasma diacron-reactive oxygen metabolites and endothelial function in Japanese patients: The GREAT clinical study, Suzuki K, Yanagi K, Shimizu M, Wakamatsu S, Niitani T, Hosonuma S, Sagara M, Aso Y, Endocrine Journal, 65（1）, 101-111, 2017年10月

  DOI
• Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM), Matsumura M, Nakatani Y, Tanka S, Aoki C, Sagara M, Yanagi K, Suzuki K, Aso Y, Diabetes Ther, 8（4）, 821-827, 2017年08月

  DOI
• The effects of intermittent use of the SGLT-2 inhibitor, dapagliflozin, in overweight patients with type 2 diabetes in Japan: a randomized, crossover, controlled clinical trial, Kato K, Suzuki K, Aoki C, Sagara M, Niitani T, Wakamatsu S, Yanagi K, Aso Y, Expert Opin Pharmacother, 18（8）, 743-751, 2017年06月

  DOI
• Primary Adrenal Leiomyosarcoma in an Aged Japanese Woman: A Rare Case Report, Aoki C, Tanaka S, Suzuki K, Sagara M, Aso Y, J Clin Case Rep, 7, 935, 2017年03月

  DOI
• Fixed-dose combination of alogliptin/pioglitazone improves glycemic control in Japanese patients with type 2 diabetes mellitus independent of body mass index, Aoki C, Suzuki K, Kuroda H, Sagara M, Shimizu M, Kasai K, Aso Y, Nagoya J Med Sci, 79（1）, 9-16, 2017年02月

  DOI
• Clinical Implication of Plasma Hydrogen Sulfide Levels in Japanese Patients with Type 2 Diabetes, Suzuki K, Sagara M, Aoki C, Tanaka S, Aso Y, Intern Med, 56（1）, 17-21, 2017年01月

  DOI
• Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case-control study, Sagara M, Suzuki K, Aoki C, Tanaka S, Taguchi I, Inoue T, Aso Y, Cardiovasc Diabetol, 15, 76, 2016年05月

  DOI
• Postprandial Reactive Hypoglycemia Treated with a Low-dose Alpha-glucosidase Inhibitor: Voglibose May Suppress Oxidative Stress and Prevent Endothelial Dysfunction, Suzuki K, Katsura D, Sagara M, Aoki C, Nishida M, Aso Y, Intern Med, 55（8）, 949-953, 2016年04月

  DOI
• Teneligliptin, a DPP-4 Inhibitor, Decreases Plasma Levels of Inflammatory Chemokines During a Standard Meal Test in Patients With Type 2 Diabetes., Aso Yoshimasa;Kase Masato;Sagara Masaaki;Sakurai Shintaro;Iijima Toshie;Tomaru Takuya;Jojima Teruo;Usui Isao, The American journal of the medical sciences, 360（3）, 261-267, 2020年

  DOIPermalink
• Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis., Sagara Masaaki;Iijima Toshie;Kase Masato;Kato Kanako;Sakurai Shintaro;Tomaru Takuya;Jojima Teruo;Usui Isao;Aso Yoshimasa, Journal of diabetes and its complications, 35（5）, 107885, 2021年02月06日

  DOIPermalink
• Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease., Aso Yoshimasa;Sagara Masaaki;Niitani Takafumi;Kato Kanako;Iijima Toshie;Tomaru Takuya;Jojima Teruo;Usui Isao, Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 69（7）, 1324-1329, 2021年05月20日

  DOIPermalink

症例報告
• Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report., Jojima Teruo;Kogai Takahiko;Iijima Toshie;Kato Kanako;Sagara Masaaki;Kezuka Atsumi;Kase Masato;Sakurai Shintaro;Akimoto Kazumi;Sakumoto Junko;Namatame Takashi;Ueki Keisuke;Hishinuma Akira;Kamai Takao;Usui Isao;Aso Yoshimasa, European journal of endocrinology, 183（6）, K7-K12, 2020年12月

  DOIPermalink